SEARCH

SEARCH BY CITATION

References

  • 1
    Alarcón-Segovia, D. & Sanchez-Guerrero, J. (1989) Primary antiphospholipid syndrome. Journal of Rheumatology, 16, 482 488.
  • 2
    Arvieux, J., Darnige, L., Caron, C., Reber, G., Bensa, J.C., Colomb, M.G. (1995) Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulant. Thrombosis and Haemostasis, 74, 1120 1125.
  • 3
    Asherson, R.A. (1988) A ‘primary’ antiphospholipid syndrome? Journal of Rheumatology, 15, 1742 1746.
  • 4
    Balestrieri, G., Tincani, A., Spatola, L., Allegri, F., Prati, E., Cattaneo, R., Valesini, G., Del Papa, N., Meroni, P. (1995) Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome? Lupus, 4, 122 130.
  • 5
    Bevers, E.M., Galli, M., Barbui, T., Comfurius, P., Zwaal, R.F.A. (1991) Lupus anticoagulant IgGs (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thrombosis and Haemostasis, 66, 629 632.
  • 6
    Brandt, J.T., Barna, L.K., Triplett, D.A. (1955) Laboratory identification of lupus anticoagulants: results of the Second International Workshop for Identification of Lupus Anticoagulants. On behalf of the Subcommittee on Lupus Anticoagulants/Antiphospholipid Antibodies of ISTH. Thrombosis and Haemostasis, 74, 1597 1603.
  • 7
    Forastiero, R., Martinuzzo, M., Cerrato, G., Kordich, L., Carreras, L. (1997) Relationship of anti-β2-glycoprotein I and anti-prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies. Thrombosis and Haemostasis, 78, 1008 1014.
  • 8
    Galli, M., Beretta, G., Daldossi, M., Bevers, E.M., Barbui, T. (1997) Different anticoagulant and immunological properties of anti-PT antibodies in patients with antiphospholipid antibodies. Thrombosis and Haemostasis, 77, 486 491.
  • 9
    Galli, M., Comfurius, P., Maassen, C., Hemker, H.C., De Baets, M.H., Van Breda-Vriesman, P.J., Barbui, T., Zwaal, R.F., Bevers, E.M. (1990) Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet, 335, 1544 1547.
  • 10
    Guerin, J., Feighery, C., Sim, R.B., Jackson, J. (1997) Antibodies to beta 2-glycoprotein I: a specific marker for the antiphospholipid syndrome. Clinical and Experimental Immunology, 109, 304 309.
  • 11
    Hughes, G.R.V., Harris, N.N., Gharavi, A.E. (1986) The anticardiolipin syndrome. Journal of Rheumatology, 13, 486 489.
  • 12
    Keeling, D.M., Wilson, A.J., Mackie, I.J., Isenberg, D.A., Machin, S. (1993) Lupus anticoagulant activity of some antiphospholipid antibodies against phospholipid bound beta 2 glycoprotein I. Journal of Clinical Pathology, 46, 665 667.
  • 13
    Loizou, S.A., Walport, M.J., Davies, K.A. (1996) The antiphospholipid syndrome in infectious diseases. The Antiphospholipid Syndrome (ed. by R. A. Asherson, R. Cervesa, J. C. Piette and Y. Shoenfeld), pp. 267 284. CRC Press, New York.
  • 14
    Love, P.E. & Santoro, S.A. (1990) Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Annals of Internal Medicine, 112, 682 698.
  • 15
    Matsuura, E., Igarashi, Y., Yasuda, T., Triplett, D.A., Koike, T. (1994) Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. Journal of Experimental Medicine, 179, 457 462.
  • 16
    McNally, T., Mackie, I.J., Machin, S.J., Isenberg, D.A. (1995) Increased levels of beta 2 glycoprotein-I antigen and beta 2 glycoprotein-I binding antibodies are associated with a history of thromboembolic complications in patients with SLE and primary antiphospholipid syndrome. British Journal of Rheumatology, 34, 1031 1036.
  • 17
    McNeil, H.P., Chesterman, C.N., Krilis, S.A. (1991) Immunology and clinical importance of antiphospholipid antibodies. Advances in Immunology, 49, 193 280.
  • 18
    McNeil, H.P., Simpson, R.J., Chesterman, C.N., Krilis, S.A. (1990) Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proceedings of the National Academy of Sciences of the United States of America, 87, 4120 4124.
  • 19
    Oosting, J.D., Derksen, R.H., Bobbink, I.W., Hackeng, T.M., Bouma, B.N., De Groot, P.G. (1993a) Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? Blood, 81, 2618 2625.
  • 20
    Oosting, J.D., Preissner, K.T., Derksen, R.H.W.M., De Groot, P.G. (1993b) Autoantibodies directed against the epidermal growth factor-like domains of thrombomodulin inhibit protein C activation in vitro. British Journal of Haematology, 85, 761 768.
  • 21
    Pengo, V., Biasiolo, A., Brocco, T., Tonetto, S., Ruffatti, A. (1996) Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies. Thrombosis and Haemostasis, 75, 721 714.
  • 22
    Permpikul, P., Rao, L.V., Rapaport, S.I. (1994) Functional and binding studies of the roles of prothrombin and beta 2-glycoprotein I in the expression of lupus anticoagulant activity. Blood, 83, 2878 2892.
  • 23
    Rao, L.V.M., Hoang, A.D., Rapaport, S.I. (1995) Differences in the interaction of lupus anticoagulant IgG with human prothrombin and bovine prothrombin. Thrombosis and Haemostasis, 73, 668 674.
  • 24
    Rao, L.V.M., Hoang, A.D., Rapaport, S.I. (1996) Mechanisms and effects of the binding of lupus anticoagulant IgG and prothrombin to phospholipid surfaces. Blood, 88, 4173 4182.
  • 25
    Roubey, R.A., Eisenberg, R.A., Harper, M.F., Winfield, J.B. (1995) ‘Anticardiolipin’ autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid: importance of Ag density and bivalent binding. Journal of Immunology, 154, 954 960.
  • 26
    Swadzba, J., De Clerck, L.S., Stevens, W.J., Bridts, C.H., Van Cotthem, K.A., Musial, J., Jankowski, M., Szczeklik, A. (1997) Prevalence of anti-β2-glycoprotein I, antiprothrombin antibodies and lupus anticoagulant in patients with systemic lupus erythematosus and a history of thrombosis . Journal of Rheumatology, 24, 1710 1715.
  • 27
    Tan, E.M., Cohen, A.S., Fries, J.F., Masi, A.T., McShane, D.J., Rothfield, N.F., Schaller, J.G., Talal, N., Winchester, R.J. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism, 25, 1271 1277.